Disagree- yes further studies will occur (2b hopefully announced soon) and pharma may not be ready to come on board yet but to say the trial wasn’t a success is incorrect. You can’t do much better than eradication - what are your criteria for a successful trial other than ‘endpoints were met’?
BOT - Anything but charting, page-1843
-
- There are more pages in this discussion • 7,495 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $2.689M | 7.299M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 472139 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 131624 | 5 |
View Market Depth
| Last trade - 15.07pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |